Inactive Instrument
Sector Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Stocks
US68403P1049
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.16% | +3.42% | +8.78% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.31B | |
| +1.70% | -2.62% | -4.97% | +1.62% | +15.26% | +21.54% | +76.69% | +225.15% | +5,375.15% | 56.95B | |
| +2.37% | +1.03% | +5.24% | +1.65% | +9.71% | +5.89% | +37.53% | -15.67% | +216.86% | 48.3B | |
| +0.50% | +2.94% | -1.11% | +9.74% | +160.74% | +344.62% | +722.17% | +640.92% | - | 44.51B | |
| +3.05% | -1.80% | -0.63% | +28.52% | +18.05% | +28.78% | +34.51% | +11.17% | +230.38% | 43.8B | |
| +1.00% | -1.46% | +0.95% | +21.50% | +19.04% | +5.17% | +111.90% | +4.12% | +1,041.57% | 41.12B | |
| -0.54% | +2.41% | -2.92% | -0.54% | +5.93% | +9.31% | +58.85% | +1.88% | +144.91% | 31.07B | |
| +4.33% | +8.04% | +19.22% | +52.91% | +83.84% | +37.62% | +32.27% | -50.00% | - | 28.97B | |
| +0.76% | -1.45% | -5.90% | +0.10% | +2.56% | -7.44% | -11.12% | -60.96% | - | 24.53B | |
| -6.56% | -11.76% | -17.78% | -6.96% | -40.34% | -33.93% | +314.66% | +291.22% | +588.07% | 22.67B | |
| +8.25% | +9.97% | +19.01% | +39.43% | +25.70% | +20.25% | +2.37% | -8.51% | +124.30% | 21.31B | |
| +3.51% | +0.74% | +4.94% | +11.28% | +10.48% | +16.53% | +154.23% | +221.01% | +1,960.81% | 17.32B | |
| +2.15% | +3.03% | -9.16% | -5.37% | +180.86% | +136.14% | +351.43% | +1,738.00% | +664.96% | 15.53B | |
| +0.07% | -0.88% | -15.72% | -16.93% | - | - | - | - | - | 14.98B | |
| +2.78% | +1.97% | +8.52% | +13.10% | +24.52% | +25.04% | +46.77% | -27.69% | +89.01% | 14.7B | |
| +0.79% | +0.82% | -0.27% | +5.37% | +34.27% | +46.79% | +165.81% | +181.44% | +348.55% | 14.58B | |
| +2.04% | +1.35% | -2.24% | -8.42% | +22.23% | -14.62% | +520.98% | - | - | 14.31B | |
| +7.09% | +5.49% | +7.72% | +34.71% | +55.79% | +75.25% | +62.58% | -22.57% | +274.56% | 14.84B | |
| +9.03% | -1.80% | +29.29% | +38.63% | +41.49% | -8.85% | - | - | - | 15.08B | |
| Average | +2.46% | -0.36% | +2.26% | +13.43% | +41.93% | +42.08% | +163.28% | +196.19% | +921.59% | 29.41B | |
| Weighted average by Cap. | +2.32% | -0.60% | +2.26% | +15.45% | +44.65% | +49.78% | +152.66% | +152.04% | +1,299.69% |
- Stock Market
- Stocks
- ORMP Stock
- Stock
- Sector Oramed Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
